Fitterfly personalises diabetes management with digital therapeutics

November 29, 2021 Bullet Article
Arbinder SingalArbinder Singal
RED 2021 Healthcare Transformation India
Share this:
Copy link
Fitterfly personalises diabetes management with digital therapeutics (RED 2021)

Fitterfly is an India-based company that provides solutions for chronic disease management. In this session, Fitterfly CEO and Co-Founder Dr Arbinder Singal discusses Diabefly, a digital therapeutics system that collects and analyses personal health data in order to deliver medical and lifestyle interventions.

Watch the full talk below.

Share this:
Copy link

More on same topic

Select a related post from the options below.

Asia’s rapidly changing health insurance landscape (RED 2021)

Gemii leverages WeChat to improve Chinese healthcare

Recommended topics

SequencingRED 2020Rare Diseases
Next Read
Management
• Articles
Creating a healthier Singapore with digital solutions: Q&A with Glenn Neo
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
Management
• Articles
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
Operations
• Articles
‘Real world evidence’ and clinical labs: a brief introduction
Operations
• Articles
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top